The Federal Ministry of Research, Technology and Space (Bundesministerium für Forschung, Technologie und Raumfahrt – BMFTR) is funding a promising new therapy approach to fighting cancer at Heinrich Heine University Düsseldorf (HHU). In the “DNAmazing” project, the team headed by Dr Manuel Etzkorn is collaborating with Professor Dr Philipp Lang from University Hospital Düsseldorf (UKD) to develop a highly selective therapeutic agent and found a new company to get it into clinical trials. The…